Tolerability of MDMA in Schizophrenia

NCT05770375 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Anya Bershad, MD, PhD

Collaborators